DOJ Sues Regeneron for Allegedly Inflating Medicare Pricing for Eye Drug Eylea

The U.S. Department of Justice announced Wednesday it has filed a False Claims Act complaint against Regeneron Pharmaceuticals, alleging that the company “fraudulently inflated Medicare reimbursement rates” for its eye therapy Eylea (aflibercept).